| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | 1,000,000 | 209,480,000 | 10.12% | Put | |
| 2 | TEVA PHARMACEUTICAL INDS LTD | 2,870,000 | 144,160,000 | 6.97% | ||
| 3 | MYLAN N V | 2,740,000 | 118,478,000 | 5.73% | ||
| 4 | GILEAD SCIENCES INC | 1,000,000 | 83,420,000 | 4.03% | Call | |
| 5 | ENDO INTL | 5,045,000 | 78,652,000 | 3.80% | ||
| 6 | CARDIOVASCULAR SYS INC DEL COM | 4,100,000 | 75,338,000 | 3.64% | ||
| 7 | MEDICINES CO | 2,000,000 | 67,260,000 | 3.25% | ||
| 8 | BIOGEN INC | 275,000 | 66,501,000 | 3.21% | ||
| 9 | CIGNA CORPORATION | 500,000 | 63,995,000 | 3.09% | ||
| 10 | GENOMIC HEALTH INC COM | 2,458,100 | 63,652,000 | 3.08% | ||
| 11 | ORTHOFIX INTERNATIONAL NV | 1,500,000 | 63,600,000 | 3.07% | ||
| 12 | GILEAD SCIENCES INC | 750,000 | 62,565,000 | 3.02% | ||
| 13 | BROOKDALE SR LIVING INC | 4,000,000 | 61,760,000 | 2.98% | ||
| 14 | SELECT MED HLDGS CORP COM | 5,575,000 | 60,600,000 | 2.93% | ||
| 15 | NEKTAR THERAPEUTICS COM | 4,250,000 | 60,478,000 | 2.92% | ||
| 16 | LIVANOVA PLC | 1,200,000 | 60,276,000 | 2.91% | ||
| 17 | TEVA PHARMACEUTICAL INDS LTD | 1,125,000 | 56,509,000 | 2.73% | Call | |
| 18 | PERRIGO CO PLC | 570,000 | 51,682,000 | 2.50% | ||
| 19 | LDR HLDG CORP COM | 1,375,000 | 50,806,000 | 2.46% | ||
| 20 | CENCORA | 625,000 | 49,575,000 | 2.40% | ||
| 21 | NUVASIVE INC COM | 750,000 | 44,790,000 | 2.16% | ||
| 22 | UNIVERSAL AMERN CORP NEW | 5,875,000 | 44,533,000 | 2.15% | ||
| 23 | Wright Medical Group NV | 2,475,000 | 42,991,000 | 2.08% | ||
| 24 | COMMUNITY HEALTH SYS INC NEW COM | 3,450,000 | 41,573,000 | 2.01% | ||
| 25 | ALKERMES PLC SHS | 937,300 | 40,510,000 | 1.96% | ||
| 26 | ENDOLOGIX INC | 3,000,000 | 37,380,000 | 1.81% | ||
| 27 | VALEANT PHARMACEUTICALS INTL | 1,656,000 | 33,352,000 | 1.61% | ||
| 28 | TENET HEALTHCARE CORP THC | 1,125,000 | 31,095,000 | 1.50% | ||
| 29 | ARIAD PHARMACEUTICALS INC | 4,000,000 | 29,560,000 | 1.43% | ||
| 30 | BIOSCRIP INC | 10,180,000 | 25,959,000 | 1.25% | ||
| 31 | INVITAE CORP | 2,746,622 | 20,298,000 | 0.98% | ||
| 32 | SYNERON MEDICAL LTD ORD SHS | 2,347,593 | 18,053,000 | 0.87% | ||
| 33 | ARENA PHARMACEUTICALS INC | 10,500,000 | 17,955,000 | 0.87% | ||
| 34 | SEQUENOM INC | 17,325,000 | 15,830,000 | 0.77% | ||
| 35 | AMAG PHARMACEUTICALS INC COM | 600,000 | 14,352,000 | 0.69% | ||
| 36 | PTC THERAPEUTICS INC | 1,500,000 | 10,530,000 | 0.51% | ||
| 37 | PROTALIX BIOTHERAPEUTICS INC | 13,275,000 | 8,496,000 | 0.41% | ||
| 38 | DURECT CORP | 6,000,000 | 7,320,000 | 0.35% | ||
| 39 | BIOLASE INC | 5,332,394 | 6,239,000 | 0.30% | ||
| 40 | PROTALIX BIOTHERAPEUTICS INC | 9,000,000 | 6,113,000 | 0.30% | PRN | |
| 41 | INNOCOLL AG | 1,059,139 | 5,836,000 | 0.28% | ||
| 42 | GENMARK DIAGNOSTICS INC COM | 649,097 | 5,647,000 | 0.27% | ||
| 43 | ORASURE TECHNOLOGIES INC | 707,559 | 4,182,000 | 0.20% | ||
| 44 | Catabasis Pharmaceuticals Inc | 1,000,000 | 3,700,000 | 0.18% | ||
| 45 | TARGACEPT INC | 1,684,799 | 1,685,000 | 0.08% | PRN | |
| 46 | DEXTERA SURGICAL | 837,483 | 1,507,000 | 0.07% | ||
| 47 | EPIRUS BIOPHARMA | 1,847,500 | 835,000 | 0.04% | ||
| 48 | BIOLASE INC | 1,841,173 | 4,000 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001654954-16-001488, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
